Study To Assess The Bioequivalence Under Fed And Fasted Conditions Of The Fesoterodine Beads-In-Capsule SR4 And SR7 Formulations And To Estimate The Bioavailability of SR7 Beads Sprinkled On Apple Sauce Relative To The Beads-In-Capsule SR7 Formulation Administer
Conditions
- Neurogenic Detrusor Overactivity
Interventions
- DRUG: Fesoterodine BIC SR4 fasted (Treatment A in Part A, Treatment G in Part B)
- DRUG: Fesoterodine BIC SR7 fasted (Treatment B in Part A, Treatment H in Part B)
- DRUG: Fesoterodine BIC SR7 fed (Treatment C in Part A, Treatment F in Part B)
- DRUG: Fesoterodine BIC SR7 on apple sauce (Treatment D in Part A)
- DRUG: Fesoterodine BIC SR4 fed (Treatment E in Part B)
Sponsor
Pfizer